Ahmed Khalil Selected Research

Ahmed Khalil Research Topics

Disease

8	Neoplasms (Cancer) 10/2021 - 05/2008
3	Breast Neoplasms (Breast Cancer) 01/2016 - 05/2005
2	Weight Gain 10/2021 - 01/2019
2	COVID-19 09/2021 - 09/2020
2	Infections 01/2019 - 04/2015
2	Hemorrhage 01/2019 - 11/2014
2	Pain (Aches) 01/2018 - 12/2017
2	Colonic Neoplasms (Colon Cancer) 01/2018 - 04/2010
2	Neoplasm Metastasis (Metastasis) 12/2017 - 02/2017
2	Glioma (Gliomas) 07/2015 - 11/2013
1	Thrombocytopenia (Thrombopenia) 01/2022
1	Pyuria 01/2022
1	Hyponatremia 01/2022
1	Hypoalbuminemia 01/2022
1	Prostatic Neoplasms (Prostate Cancer) 01/2022
1	Stroke (Strokes) 09/2021
1	Renal Cell Carcinoma (Grawitz Tumor) 06/2021
1	Carcinoma (Carcinomatosis) 06/2021
1	Papillary Carcinoma 06/2021
1	Anemia 03/2021
1	Acute Kidney Injury (Acute Renal Failure) 01/2020
1	Bradycardia 01/2020
1	Heart Arrest (Cardiac Arrest) 01/2020
1	Congenital Heart Defects (Congenital Heart Defect) 01/2020
1	Down Syndrome (Down's Syndrome) 01/2019
1	Hypothyroidism 01/2019
1	Stomach Neoplasms (Stomach Cancer) 10/2018
1	Body Weight (Weight, Body) 01/2018
1	Vascular Diseases (Vascular Disease) 01/2018
1	Non-alcoholic Fatty Liver Disease 01/2018
1	Postoperative Pain 01/2018
1	Disease Progression 12/2017
1	Polyploidy 04/2017
1	Ductal Carcinoma 02/2017
1	Brain Injuries (Brain Injury) 01/2017
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2017
1	Colorectal Neoplasms (Colorectal Cancer) 04/2016
1	Ovarian Neoplasms (Ovarian Cancer) 03/2016
1	Hypertension (High Blood Pressure) 03/2016
1	Aneurysm (Aneurysms) 04/2015
1	Head and Neck Neoplasms (Head and Neck Cancer) 11/2014

Drug/Important Bio-Agent (IBA)

3	Leucovorin (Folinic Acid)FDA Link 01/2018 - 04/2010
3	Fluorouracil (Carac)FDA LinkGeneric 01/2018 - 04/2010
3	thymidine kinase 1IBA 07/2015 - 01/2012
2	Colchicine FDA LinkGeneric 09/2021 - 09/2020
2	Triglycerides (Triacylglycerol)IBA 01/2018 - 04/2017
2	NucleosidesIBA 07/2015 - 04/2013
1	Hemoglobins (Hemoglobin)IBA 01/2022
1	fibrin fragment D (D-dimer)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2021
1	Contrast MediaIBA 09/2021
1	Fumarate Hydratase (Fumarase)IBA 06/2021
1	RHO(D) antibody (anti-D)IBA 03/2021
1	Fetal Hemoglobin (Hemoglobin F)IBA 03/2021
1	Atropine FDA LinkGeneric 01/2020
1	CreatinineIBA 01/2020
1	AntibodiesIBA 01/2019
1	Prednisone (Sone)FDA LinkGeneric 01/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2019
1	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2019
1	Narcotics (Narcotic Analgesics)IBA 01/2018
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2018
1	Capecitabine (Xeloda)FDA Link 01/2018
1	2,2',4,4'-tetrabromodiphenyl etherIBA 01/2018
1	LipidsIBA 01/2018
1	pentabromodiphenyl ether (PBDE)IBA 01/2018
1	Estrogen ReceptorsIBA 12/2017
1	Fatty Acids (Saturated Fatty Acids)IBA 04/2017
1	Insulin (Novolin)FDA Link 04/2017
1	Hormones (Hormone)IBA 02/2017
1	ErbB Receptors (EGF Receptor)IBA 02/2017
1	Proteins (Proteins, Gene)FDA Link 01/2017
1	Pharmaceutical PreparationsIBA 01/2017
1	3- (2,4- dichloro- 5- methoxyphenyl)- 2- sulfanyl- 4(3H)- quinazolinoneIBA 01/2017
1	Dynamins (Dynamin)IBA 01/2017
1	GTP Phosphohydrolases (GTPases)IBA 01/2017
1	Irinotecan (Camptosar)FDA LinkGeneric 04/2016
1	Bevacizumab (Avastin)FDA Link 03/2016
1	Trastuzumab (Herceptin)FDA Link 01/2016
1	Monoclonal AntibodiesIBA 01/2016
1	pertuzumabIBA 01/2016
1	Docetaxel (Taxotere)FDA Link 01/2016
1	pyrimidineIBA 07/2015
1	Thymidine KinaseIBA 07/2015
1	EnzymesIBA 07/2015

Therapy/Procedure

6	Therapeutics 10/2021 - 05/2008
4	Drug Therapy (Chemotherapy) 10/2018 - 05/2005
3	Radiotherapy 11/2014 - 05/2008
2	Adjuvant Chemotherapy 01/2018 - 05/2005
2	Boron Neutron Capture Therapy 07/2015 - 04/2013
2	Stents 04/2015 - 11/2014
1	Cardiopulmonary Resuscitation (CPR) 01/2020
1	Laparoscopic Cholecystectomy 01/2020
1	General Anesthesia 01/2020
1	Enteral Nutrition (Feeding, Tube) 01/2019
1	Duration of Therapy 01/2018
1	Enhanced Recovery After Surgery 01/2018
1	Splenectomy 12/2017
1	Chemoradiotherapy 11/2014